Cullinan Therapeutics, Inc. ($CGEM)
Filing Information
| Accession Number | 0001193125-26-387381 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 10, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
16,000
Total Value
$189,760.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Sep 8, 2026 | Exercise/Conversion | 4,000 | $4.30 | $17,200.00 | 166,844 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Sep 8, 2026 | Sale | 8,000 | $21.57 | $172,560.00 | 158,844 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Sep 8, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 78,987 | Direct | โ | View Details |